Skip to main content

Tysabri 300 mg/15 mL injection for intravenous infusion Images

Generic Name: natalizumab

This medication has been identified as Tysabri 300 mg/15 mL injection for intravenous infusion. It is supplied by Biogen.

Tysabri is used in the treatment of Multiple Sclerosis; Crohn's Disease, Maintenance and belongs to the drug class selective immunosuppressants. Risk cannot be ruled out during pregnancy. Tysabri 300 mg/15 mL injection for intravenous infusion is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Tysabri 300 mg/15 mL injection for intravenous infusion medicine

Tysabri

Generic Name
natalizumab
Strength
300 mg/15 mL injection for intravenous infusion
Availability
Prescription only
Drug Class
Selective immunosuppressants
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Biogen
National Drug Code (NDC)
64406-0008

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.